Integrative analysis of promising molecular biomarkers and pathways for coronary artery disease using WGCNA and MetaDE methods
- Authors:
- Published online on: July 16, 2018 https://doi.org/10.3892/mmr.2018.9277
- Pages: 2789-2797
-
Copyright: © Yan . This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
Coronary artery disease (CAD) remains one of the most common causes of morbidity and mortality globally, with an increased prevalence predicted in the near future (1). The occurrence of CAD events is primarily due to crosstalk between genetic and environmental factors (2). A number of risk factors of CAD have been identified, including smoking, obesity and family history (3). Available treatment options primarily include lifestyle alterations, medical treatment and surgical interventions, which are chosen depending on comorbidities and the preferences of the individual patient (4). Prevention and treatment of this disease remains a daunting task. Therefore, further research is required to elucidate the underlying biological features for the development of more adequate therapy for patients.
The rapid prevalence of high-throughput microarray technologies has facilitated identification of genome variations in diseases, contributing to a deeper understanding of pathogenesis and the development of promising biomarkers (5,6). Such technologies have been applied to investigate the underlying mechanisms of CAD. Ren et al (7) identified a circulating micro (mi)RNA signature for CAD using co-expression network analyses on miRNA array data. In addition, a study of genomic DNA methylation profiling in patients with CAD was conducted (8). Furthermore, Liu et al (9) performed a secondary analysis using a weighted gene co-expression network (WGCNA) on microarray data of CAD samples (dataset no. GSE23561), which were downloaded from the Gene Expression Omnibus (GEO) database. It was identified that the glucose-6-phosphate 1-dehydrogenase, protein S100-A7 and hypertrophic cardiomyopathy pathways were involved in CAD (9). However, this previous study had the limitation of sample size (six CAD samples and nine normal samples).
Therefore, four microarray datasets of CAD from the GEO database were included in the present study. WGCNA was used to construct a co-expression network and the highly preserved modules in the four datasets were determined. The MetaDE method in R language, which is capable of conducting 12 primary meta-analysis methods (10), has been utilized for the detection of differentially expressed genes (DEGs) in a number of diseases, including gastric cancer (11) and colorectal cancer (12). In the present study, the DEGs with significant consistency across all four datasets were selected using the MetaDE method and subsequently compared with the genes in the highly preserved WGCNA modules. Subsequently, the overlapping genes were used to construct a protein-protein interaction (PPI) network, followed by functional analysis of the genes in the network. The in-depth analysis conducted in the present study may provide novel insights into the pathogenesis of CAD.
Materials and methods
Microarray data
Microarray data for CAD were searched in NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/). Inclusion criteria were: i) The dataset belonged to a gene expression profile; ii) samples in the dataset were collected from blood; iii) the samples included patients and healthy controls; iv) the dataset was based on human gene expression profiles; and v) the sample number was ≥20. A total of four datasets, GSE12288 (n=222; CAD, 112; control, 110) (13), GSE20680 (n=139; CAD, 87; control, 52) (14), GSE20681 (n=198; CAD, 99; control, 99) (15) and GSE42148 (n=24; CAD, 13; control, 11; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42148) that met the criteria were included in the present study (Table I).
Data preprocessing
Raw data in CEL files from GSE12288 were downloaded from the Affy platform (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL96) and subsequently converted into gene symbols under pretreatment. The median method was used to fill in the missing values, the MicroArray Suite method to complete background correction, and the quantiles method to normalize the data, using oligo 1.41.1 in R3.3.1 language (http://www.bioconductor.org/packages/release/bioc/html/oligo.html) (16). GSE20680, GSE20681 and GSE42148 were downloaded from the Agilent platform (Agilent Technologies, Inc., Santa Clara, CA, USA). Microarray raw data (TXT files) of the three datasets were log2-transformed using Limma 3.34.0 (https://bioconductor.org/packages/release/bioc/html/limma.html) to achieve an approximate normal distribution, and were subsequently standardized using the median normalization method (17).
WGCNA analysis
WGCNA is a well-established method for constructing scale-free gene co-expression networks, which is characterized by the use of soft thresholding (18,19). GSE12288 was used as the training dataset, while GSE20680, GSE20681 and GSE42148 were the validations sets. Genes with coefficients of variation <0.1 were discarded. Correlations between the gene expression in the four datasets were evaluated with the verboseScatterplot function of the WGCNA package (https://labs.genetics.ucla.edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/). Weighted gene co-expression networks of the genes in the training dataset were constructed using the WGCNA method as previously described (20–22). First, the soft threshold power of β was set as 18 (scale-free R2=0.9), according to the scale free topology criterion. The weighted adjacency matrix was subsequently constructed. Adjacencies and correlations were transformed into a topological overlap matrix (TOM), followed by calculating the corresponding dissimilarity (1-TOM). Subsequently, a hierarchical clustering analysis (23) of genes was performed using 1-TOM as the distance measure. Modules were detected using dynamic tree cut algorithm with a minimum module size of 50 and a minimum cut height of 0.95. Furthermore, module preservation between the training set and the three validation sets was measured using the module preservation function of the WGCNA software package. Possible functions of the preserved module were studied using the user List Enrichment function of the WGCNA package.
Identification of DEGs with significant consistency in four datasets
DEGs between CAD samples and healthy controls were screened in each of the above four datasets using the metaDE method (10,24) in R language (https://cran.r-project.org/web/packages/MetaDE/). Heterogeneity was examined across the four datasets to assess the consistency of gene expression, by calculating tau2 and Qpval values. A tau2=0 and Qpval >0.05 indicated that the gene was homogeneous and unbiased. The thresholds for DEG identification were tau2=0, Qpval >0.05 and false discovery rate <0.05. Consistency of the DEGs was detected using the MetaDE method, and the DEGs with significant consistency in the four datasets were selected for further analysis.
Construction of a PPI network
A PPI network was constructed to evaluate the interactions between genes in the above network. The common genes in the preserved modules that were obtained from WGCNA, and the DEGs with significant consistency, were selected to construct a PPI network based on three databases: The Biological General Repository for Interaction Datasets 3.4.153 (http://thebiogrid.org/) (25); the Human Protein Reference Database Release 9 (http://www.hprd.org/) (26); and STRING 10.5 (https://string-db.org/) (27). The PPIs revealed in at least two of the three databases were extracted for the PPI network, visualized using Cytoscape 3.3 software (http://www.cytoscape.org/) (28). In the PPI network, a node represents a gene; the undirected link between two nodes is an edge, denoting the interaction between two genes; and the degree of a node corresponds to the number of interactions of a gene with other genes in the network.
Gene ontology (GO) functional and kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses
In order to elucidate the possible biological roles of the genes in the PPI network, GO (29) functional and KEGG (30) pathway enrichment analyses were performed using the Database for Annotation, Visualization and Integrated Discovery 6.8 software (31). GO terms have three categories, including biological process (BP), cellular compartment and molecular function. P<0.05 was considered to indicate a significant difference for GO terms and KEGG pathways.
Results
Identification of key WGCNA modules
Following data preprocessing for the four datasets, the present study attempted to identify CAD-associated co-expression modules using WGCNA. Using the aforementioned methods, the correlation coefficients (CCs) of genes in the four datasets were obtained, and the CCs were 0.47–0.92 with P-values <1×10−200 between any two datasets (Fig. 1), suggesting a good consistency of the common genes across all datasets.
As a result, 11 co-expression modules were identified for genes in the training set using WGCNA (Fig. 2A). These modules are illustrated in branches of the dendrogram with different colors. To evaluate the robustness of these modules in the training set, the modules were re-constructed in the three validation datasets, GSE20680, GSE20681 and GSE42148, separately (Fig. 2B-D). Genes in the three validation sets were colored, according to the module color in the training set. Multi-dimensional scaling of expression data of all genes in these modules demonstrated that genes in the same module appeared to cluster together and exhibited a similar expression pattern (Fig. 3A). Additionally, hierarchical clustering analysis of these modules in the four datasets revealed that modules of the same branch tended to have similar gene expression patterns (Fig. 3B).
In total, five of the 11 modules, black, brown, magenta, turquoise and yellow modules, with Z-scores >5 were determined to be well preserved across the four datasets, including 873 genes (Table II). This suggested that the five highly preserved modules may be closely associated with CAD. Of the five modules, genes in the black module were significantly linked to ‘response to glucocorticoid stimulus’; those in the brown module were significantly associated with ‘regulation of transcription’; and those in the magenta module may be involved in ‘protein localization’ (Table II). Notably, the turquoise and the yellow module exhibited functions in ‘immune response’ (Table II).
Screening for DEGs with significant consistency in the four datasets
Using the metaDE method, 836 DEGs were identified with significant consistency across the four datasets. A heatmap for these DEGs demonstrated that the expression patterns of these DEGs differed between the CAD and control samples (Fig. 4).
Construction of a PPI network for the overlapping genes
A total of 177 genes were overlapping between WGCNA modules and the DEGs with significant consistency (Fig. 5A). Of them, 92 genes were included in the turquoise module, 26 in the yellow module, 16 in the black module, 31 in the brown module and 12 in the magenta module (Fig. 5B). Based on the three databases mentioned above, a PPI network was built with these overlapping genes. In total, 150 paired PPIs that appeared in at least two of the three databases were included in the PPI network (Fig. 6A), which contained 59 downregulated genes and 40 upregulated genes (Fig. 6B). All genes in the network were ranked in a descending order, according to their degrees. The top five genes were LCK proto-oncogene, Src family tyrosine kinase (LCK; degree=15), euchromatic histone lysine methyltransferase 2 (EHMT2; degree=14), inosine monophosphate dehydrogenase 2 (IMPDH2; degree=12), protein phosphatase 4 catalytic subunit (PPP4C; degree=11) and ζ-chain of T-cell receptor associated protein kinase 70 (ZAP70; degree=11).
Functional annotation
The enrichment analysis indicated that genes in the PPI network were significantly associated with numerous GO BP terms, including the ‘transmembrane receptor protein tyrosine kinase signaling pathway’ and ‘peptidyl-tyrosine autophosphorylation’ (Table III). With regard to KEGG pathways, there were five significant pathways, including ‘metabolic pathways’, ‘natural killer cell mediated cytotoxicity’, ‘fructose and mannose metabolism’, ‘primary immunodeficiency’, and ‘Fc gamma R-mediated phagocytosis’ (Table IV). Notably, ‘natural killer cell mediated cytotoxicity’ and ‘primary immunodeficiency’ pathways were significantly enriched with LCK and ZAP70.
Discussion
CAD remains a primary public health concern (32). The present study attempted to dissect the underlying pathogenic mechanisms of CAD via a combined analysis of four GEO datasets, which contained CAD samples and healthy control samples. A total of 11 modules were detected in the WGCNA network, five of which were highly preserved across all datasets. Using the metaDE method, 836 common DEGs in the four datasets were identified. Furthermore, a PPI network was constructed with the 177 overlapping genes of the DEGs with significant consistency and the five preserved WGCNA modules. According to degree, the top five genes of the PPI network were LCK, EHMT2, IMPDH2, PPP4C and ZAP70. Notably, multiple significant pathways for genes in the PPI network were identified, including ‘natural killer cell mediated cytotoxicity’, ‘primary immunodeficiency’, and ‘Fc gamma R-mediated phagocytosis’ pathways.
The LCK protein encoded by the gene LCK, additionally termed lymphocyte-specific protein tyrosine kinase, is a member of the Src family of tyrosine kinases, which are involved in T cell signaling (33). Insufficient deactivation of LCK has been demonstrated to render patients with acute coronary syndrome (ACS) vulnerable to abnormal T cell responses (34). The ZAP-70 gene encodes the ZAP-70 enzyme, which belongs to the protein-tyrosine kinase family and is a T cell receptor. In T cell signaling, ZAP-70 binds to the CD3 complex that is phosphorylated by the LCK protein (35). It has been established that the ZAP-70 protein expression is able to act as a marker for chronic lymphocytic leukemia or small lymphocytic lymphoma (36).
In the present study, LCK (degree=15) and ZAP70 (degree=11) were highlighted in the PPI network. Furthermore, based on the KEGG pathway enrichment analysis, LCK and ZAP70 were significantly associated with ‘natural killer cell mediated cytotoxicity’ and ‘primary immunodeficiency’ pathways, which were associated with immune processes. Similarly, there is evidence that dysregulated adaptive immunity serves a causative role in ACS (37). Therefore, it may be inferred that LCK and ZAP70 serve a role in CAD, which may partly be by regulating natural killer cell mediated cytotoxicity and primary immunodeficiency pathways. Additionally, a previous study with a novel knowledge-based approach revealed that the Fc gamma R-mediated phagocytosis pathway is a pathogenic mechanism for CAD (38). Likewise, the present study suggests that ‘Fc gamma R-mediated phagocytosis’ may have a function in CAD.
EHMT2, encoded by the gene EHMT2, termed G9a, is a histone methyltransferase that serves a critical role in epigenetic regulation within the nucleus accumbens (39). Histone methylation has emerged as a crucial epigenetic mechanism for cardiovascular development and homeostasis (40). Papait et al (41) demonstrated that EHMT2 orchestrates important epigenetic alterations in cardiomyocyte homeostasis and hypertrophy. Furthermore, EHMT1/2 has been suggested to be a therapeutic target against pathological cardiac hypertrophy (42). These results are in accordance with the present results, which demonstrated that EHMT2 was a predominant gene in the PPI network (degree=14). These collectively suggest a potentially critical role of EHMT2 in CAD.
IMPDH2, encoded by gene IMPDH2, termed IMP dehydrogenase 2, acts as a rate-limiting enzyme in guanine nucleotide biosynthesis (43). It has been reported to be involved in a number of cancer types, including primary nasopharyngeal carcinoma (44) and prostate cancer (45). Nonetheless, the role of IMPDH2 in CAD has been poorly defined. The PPP4C gene encodes the PP4C protein, which is a member of the type 2 serine/threonine protein phosphatase family (46), and partly regulates the phosphorylation of numerous proteins implicated in cardiac physiology and hypertrophy (47,48). The present study indicated that IMPDH2 and PPP4C may be important genes in CAD.
Although a comprehensive bioinformatics analysis using four datasets was performed, there were a number of limitations. The potentially important genes associated with CAD lacked gene expression and functional validation. Further studies are required with substantial experiments in vivo and in vitro. Furthermore, the four datasets were not from the same platform, which may cause numerous deviations. Nevertheless, the present study provides novel insight into CAD pathogenesis.
In conclusion, the present study revealed that LCK, EHMT2, IMPDH2, PPP4C and ZAP70 may be proposed as genetic biomarkers for CAD. They may function via the involvement of the ‘natural killer cell mediated cytotoxicity’, ‘primary immunodeficiency’, and ‘Fc gamma R-mediated phagocytosis pathways’ in CAD. These results require further validation with substantial experiments.
Acknowledgements
Not applicable.
Funding
No funding was received.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Authors' contributions
SY performed data analyses, wrote the manuscript, conceived and designed the study.
Ethics approval and consent to participate
In the original article of the datasets, the trials were approved by the local institutional review boards of all participating centers and informed consent was obtained from all patients.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
References
Ohira T and Iso H: Cardiovascular disease epidemiology in Asia: An overview. Circ J. 77:1646–1652. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sayols-Baixeras S, Lluís-Ganella C, Lucas G and Elosua R: Pathogenesis of coronary artery disease: Focus on genetic risk factors and identification of genetic variants. Appl Clin Genet. 7:15–32. 2014.PubMed/NCBI | |
Torpy JM, Burke AE and Glass RM: Coronary heart disease risk factors. JAMA. 302:23882009. View Article : Google Scholar : PubMed/NCBI | |
Hanson MA, Fareed MT, Argenio SL, Agunwamba AO and Hanson TR: Coronary artery disease. Prim Care. 40:1–16. 2013. View Article : Google Scholar : PubMed/NCBI | |
Callaway JL, Shaffer LG, Chitty LS, Rosenfeld JA and Crolla JA: The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: A review of the literature. Prenat Diagn. 33:1119–1133. 2013. View Article : Google Scholar : PubMed/NCBI | |
Abulwerdi FA and Schneekloth JS Jr: Microarray-based technologies for the discovery of selective, RNA-binding molecules. Methods. 103:188–195. 2016. View Article : Google Scholar : PubMed/NCBI | |
Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, Li S, Zhao J and Chen H: Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One. 8:e807382013. View Article : Google Scholar : PubMed/NCBI | |
Sharma P, Garg G, Kumar A, Mohammad F, Kumar SR, Tanwar VS, Sati S, Sharma A, Karthikeyan G, Brahmachari V and Sengupta S: Genome wide DNA methylation profiling for epigenetic alteration in coronary artery disease patients. Gene. 541:31–40. 2014. View Article : Google Scholar : PubMed/NCBI | |
Liu J, Jing L and Tu X: Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease. BMC Cardiovasc Disord. 16:542016. View Article : Google Scholar : PubMed/NCBI | |
Wang X, Kang DD, Shen K, Song C, Lu S, Chang LC, Liao SG, Huo Z, Tang S, Ding Y, et al: An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection. Bioinformatics. 28:2534–2536. 2012. View Article : Google Scholar : PubMed/NCBI | |
Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y and Ma L: Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer. Onco Targets Ther. 9:2975–2986. 2016.PubMed/NCBI | |
Qi C, Hong L, Cheng Z and Yin Q: Identification of metastasis-associated genes in colorectal cancer using metaDE and survival analysis. Oncol Lett. 11:568–574. 2016. View Article : Google Scholar : PubMed/NCBI | |
Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD, Kraus WE, Sketch M Jr, Nelson C, Ginsburg GS, et al: Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS One. 4:e70372009. View Article : Google Scholar : PubMed/NCBI | |
Elashoff MR, Wingrove JA, Beineke P, Daniels SE, Tingley WG, Rosenberg S, Voros S, Kraus WE, Ginsburg GS, Schwartz RS, et al: Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 4:262011. View Article : Google Scholar : PubMed/NCBI | |
Beineke P, Fitch K, Tao H, Elashoff MR, Rosenberg S, Kraus WE and Wingrove JA: PREDICT Investigators: A whole blood gene expression-based signature for smoking status. BMC Med Genomics. 5:582012. View Article : Google Scholar : PubMed/NCBI | |
Parrish RS and Spencer HJ III: Effect of normalization on significance testing for oligonucleotide microarrays. J Biopharm Stat. 14:575–589. 2004. View Article : Google Scholar : PubMed/NCBI | |
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI | |
Langfelder P and Horvath S: WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI | |
Zhang B and Horvath S: A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 4:Article17. 2005. View Article : Google Scholar : PubMed/NCBI | |
Zhai X, Xue Q, Liu Q, Guo Y and Chen Z: Colon cancer recurrence-associated genes revealed by WGCNA co-expression network analysis. Mol Med Rep. 16:6499–6505. 2017. View Article : Google Scholar : PubMed/NCBI | |
Vilne B, Skogsberg J, Asl Foroughi H, Talukdar HA, Kessler T, Björkegren JLM and Schunkert H: Network analysis reveals a causal role of mitochondrial gene activity in atherosclerotic lesion formation. Atherosclerosis. 267:39–48. 2017. View Article : Google Scholar : PubMed/NCBI | |
Min S, Sun T, He Z and Xiong B: Identification of two novel biomarkers of rectal carcinoma progression and prognosis via co-expression network analysis. Oncotarget. 8:69594–69609. 2017.PubMed/NCBI | |
Yip AM and Horvath S: Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics. 8:222007. View Article : Google Scholar : PubMed/NCBI | |
Hui L, Zhang J, Ding X, Guo X and Jang X: Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling. Oncol Lett. 14:7171–7178. 2017.PubMed/NCBI | |
Chatraryamontri A, Breitkreutz BJ, Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A, Kolas N, O'Donnell L, et al: The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43:(Database Issue). D470–D478. 2015. View Article : Google Scholar : PubMed/NCBI | |
Prasad Keshava TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, et al: Human protein reference database-2009 update. Nucleic Acids Res. 37:(Database Issue). D767–D772. 2009. View Article : Google Scholar : PubMed/NCBI | |
Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, et al: The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39:(Database Issue). D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI | |
Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q and Bader GD: Cytoscape Web: An interactive web-based network browser. Bioinformatics. 26:2347–2348. 2010. View Article : Google Scholar : PubMed/NCBI | |
Gene Ontology Consortium: Gene ontology consortium: Going forward. Nucleic Acids Res. 43:(Database Issue). D1049–D1056. 2015. View Article : Google Scholar : PubMed/NCBI | |
Kanehisa M, Sato Y, Kawashima M, Furumichi M and Tanabe M: KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44(D1): D457–D462. 2016. View Article : Google Scholar : PubMed/NCBI | |
da Huang W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI | |
Hanson MA, Fareed MT, Argenio SL, Agunwamba AO and Hanson TR: Coronary artery disease. Prim Care. 40:1–16. 2013. View Article : Google Scholar : PubMed/NCBI | |
Patil DP and Kundu GC: LCK (lymphocyte-specific protein tyrosine kinase). Atlas Genet Cytogenet Oncol Haematol. 9:229–230. 2005. | |
Pryshchep S, Goronzy JJ, Parashar S and Weyand CM: Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome. Circ Res. 106:769–778. 2010. View Article : Google Scholar : PubMed/NCBI | |
Pelosi M, Di Bartolo V, Mounier V, Mège D, Pascussi JM, Dufour E, Blondel A and Acuto O: Tyrosine 319 in the interdomain B of ZAP-70 is a binding site for the Src homology 2 domain of Lck. J Biol Chem. 274:14229–14237. 1999. View Article : Google Scholar : PubMed/NCBI | |
Staudt LM, Rosenwald A, Wilson W, Barry TS and Wiestner A: ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). US Patent 7,981,610 B2. Filed December 12, 2007; issued July 19. 2011. | |
Flego D, Liuzzo G, Weyand CM and Crea F: Adaptive immunity dysregulation in acute coronary syndromes: From cellular and molecular basis to clinical implications. J Am Coll Cardiol. 68:2107–2117. 2016. View Article : Google Scholar : PubMed/NCBI | |
Li H, Zuo X, Ouyang P, Lin M, Zhao Z, Liang Y, Zhong S and Rao S: Identifying functional modules for coronary artery disease by a prior knowledge-based approach. Gene. 537:260–268. 2014. View Article : Google Scholar : PubMed/NCBI | |
Tachibana M, Sugimoto K, Fukushima T and Shinkai Y: Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity nd specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem. 276:25309–25317. 2001. View Article : Google Scholar : PubMed/NCBI | |
Zhang QJ and Liu ZP: Histone methylations in heart development, congenital and adult heart diseases. Epigenomics. 7:321–330. 2015. View Article : Google Scholar : PubMed/NCBI | |
Papait R, Serio S, Pagiatakis C, Rusconi F, Carullo P, Mazzola M, Salvarani N, Miragoli M and Condorelli G: Histone methyltransferase G9a is required for cardiomyocyte homeostasis and hypertrophy. Circulation. 136:1233–1246. 2017. View Article : Google Scholar : PubMed/NCBI | |
Thienpont B, Aronsen JM, Robinson EL, Okkenhaug H, Loche E, Ferrini A, Brien P, Alkass K, Tomasso A, Agrawal A, et al: The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy. J Clin Invest. 127:335–348. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bremer S, Rootwelt H and Bergan S: Real-time PCR determination of IMPDH1 and IMPDH2 expression in blood cells. Clin Chem. 53:1023–1029. 2007. View Article : Google Scholar : PubMed/NCBI | |
Xu Y, Zheng Z, Gao Y, Duan S, Chen C, Rong J, Wang K, Yun M, Weng H, Ye S and Zhang J: High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma. Sci Rep. 7:7452017. View Article : Google Scholar : PubMed/NCBI | |
Zhou L, Xia D, Zhu J, Chen Y, Chen G, Mo R, Zeng Y, Dai Q, He H, Liang Y, et al: Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer. Clin Transl Oncol. 16:906–913. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gingras AC, Caballero M, Zarske M, Sanchez A, Hazbun TR, Fields S, Sonenberg N, Hafen E, Raught B and Aebersold R: A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol Cell Proteomics. 4:1725–1740. 2005. View Article : Google Scholar : PubMed/NCBI | |
Eleftheriadou O, Longman MR, Boguslavskyi A, Ryan A, Wadzinski BE, Shattock MJ and Snabaitis AK: Expression of type 2a protein phosphatases in cardiac health and disease. Heart. 100:A162014. View Article : Google Scholar | |
Eleftheriadou O, Boguslavskyi A, Longman MR, Cowan J, Francois A, Heads RJ, Wadzinski BE, Ryan A, Shattock MJ and Snabaitis AK: Expression and regulation of type 2A protein phosphatases and alpha4 signalling in cardiac health and hypertrophy. Basic Res Cardiol. 112:372017. View Article : Google Scholar : PubMed/NCBI |